Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
E-Mart | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩2.06T | -4.6x | 0.02 | ₩75,300 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.7% Upside | Upgrade to Pro+ | |
BGF Retail | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩1.87T | 10.5x | -1.83 | ₩106,700 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31% Upside | Upgrade to Pro+ | |
Gs Retail | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩1.39T | -16.6x | 0.06 | ₩16,370 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.2% Upside | Upgrade to Pro+ | |
Hyundai Green Food | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩498.85B | 7x | 0.32 | ₩15,140 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.1% Downside | Upgrade to Pro+ | |
SPC Samlip | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩432.01B | 10.3x | -0.22 | ₩52,700 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curexo | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩359.54B | -14.6x | ₩8,530 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
CJ Freshway | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩335.97B | 13.4x | -0.27 | ₩27,950 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.1% Upside | Upgrade to Pro+ | |
Kyochon | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩226.09B | 18x | 0.2 | ₩4,415 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shinsegae Food | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩161.09B | 7.8x | 0.11 | ₩41,550 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.2% Upside | Upgrade to Pro+ | |
Seouleaguer | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩78.51B | -249.3x | -3.47 | ₩908 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Boratr | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩61.1B | 9.8x | -0.29 | ₩9,240 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CuroHoldings | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩39.17B | -0.7x | 0.04 | ₩1,690 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nara Cellar | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩32.82B | -17.6x | -0.26 | ₩2,565 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
KBio Company | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩29.34B | -2.5x | 0 | ₩250 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |